Showing results (1521-1530 of 1,861) with videos related to

Sort By:
Pageof 187
Journal of Oncology Navigation & Survivorship|November 22, 2021
Addressing Barriers to Fertility Preservation for Cancer Patients: The Role of Oncofertility Patient NavigationCaroline S Dorfman, Juliann M Stalls, Coleman Mills, et al.
The Journal of Infectious Diseases|December 1, 1993
Longitudinal analysis of the humoral immune response to human immunodeficiency virus type 1 (HIV-1) gp160 epitopes in rapidly progressing and nonprogressing HIV-1-infected subjectsM T Wong, R Q Warren, S A Anderson, et al.
Molecular Vision|October 2, 2002
Decreased heat stability and increased chaperone requirement of modified human betaB1-crystallinsKirsten J Lampi, Yung H Kim, Hans Peter Bächinger, et al.
Annals of Internal Medicine|August 1, 1993
Delayed-type hypersensitivity skin testing predicts progression to AIDS in HIV-infected patientsS P Blatt, C W Hendrix, C A Butzin, et al.
Cell Reports|October 31, 2025
In vivo differentiation of embryonic cells devoid of key reprogramming factorsScott E Youlten, Liyun Miao, Caroline Hoppe, et al.
Sleep Medicine|January 29, 2013
Treatment outcomes in REM sleep behavior disorderStuart J McCarter, Christopher L Boswell, Erik K St Louis, et al.
Pain Physician|July 29, 2015
A Best-Evidence Systematic Appraisal of the Diagnostic Accuracy and Utility of Facet (Zygapophysial) Joint Injections in Chronic Spinal PainMark V Boswell, Laxmaiah Manchikanti, Alan D Kaye, et al.
Epidemiology (Cambridge, Mass.)|July 28, 2015
Multiple Imputation to Account for Measurement Error in Marginal Structural ModelsJessie K Edwards, Stephen R Cole, Daniel Westreich, et al.
European Journal of Radiology Open|September 18, 2020
Comparative analysis of three-dimensional volume rendering and maximum intensity projection for preoperative planning in liver cancerJoyce L Ho, Anuja Konda, Jawaria Rahman, et al.
Pharmaceutics|January 28, 2026
Correction: Susilo et al. Whole-Body Physiologically Based Pharmacokinetic Modeling Framework for Tissue Target Engagement of CD3 Bispecific Antibodies. Pharmaceutics 2025, 17, 500Monica E Susilo, Stephan Schaller, Luis David Jiménez-Franco, et al.
Pageof 187